Table 1: Baseline characteristics of the participants.

All

N 1003
Age (±SD) years
Male gender (%)523 (52%)
Body mass index (±SD) kg/
Medication use at diagnosis (%)250 (25%)
Tested for mutation (% of total)
 LDLR-c.313+1/2140 (14%)
 LDLR-p.S306L80 (8%)
LDLR-c. −1G>A110 (11%)
 LDLR-p.N564H/2393del9bp317 (32%)
 APOB-p.R3527 L/Q/W 348 (35%)
 LDLR-c.313+1/2+c.191−28 (1%)

Based on the per protocol study population: subjects tested when aged under 18 years were excluded.